Trial intelligence / Profile preview

Stem Cell Transplantation with or without G-CSF in Critical Limb Ischemia

NCT00677404Phase 2Completed

Sponsor
Royan Institute
Start
Jan 2008
Primary completion
Oct 2009
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of autologous bone marrow-derived mononuclear cell in critical limb ischemia (CLI), sponsored by Royan Institute. Started Jan 2008; status: completed.

02

Drugs

autologous bone marrow-derived mononuclear cell
03

Conditions

critical limb ischemia (CLI)

Beyond the preview

Go deeper on NCT00677404.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00677404.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call